BDH today exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe etc.
The Government of the India has accorded "Star Export House" status to BDH and also accredited with WHO-GMP Certification since 1982 and ISO 9001:2015 by SGS (UK) Limited.
- Recognition and Registration of Research & Development
(R & D) Centre by Dept. of Scientific and Industrial Research
(DSIR), Ministry of Science & Technology, Govt. of India.
-
Federation of Indian Export Organisations (FIEO) Export Award "NIRYAT SHREE" 2001-2002 & 2008-2009
-
“Good Corporate Citizen” Award by Bombay Chamber of Commerce & Industry 2010
-
State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
-
“STAR Export House” status by Govt. of India.
-
WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2017
-
WHO-GMP Certificatation for over 170 products
-
ISO 9001:2015 Certification from SGS UK
-
Chemexcil TOP Export Award
-
Chemexcil Trishul Award for Consistent Export Performance
-
Government of Maharashtra Export Award
-
Ministry of Commerce's Award from the President of India.
As stated at the outset, at BDH we CARE for QUALITY. Our REPUTATION is a result of that.
Our goal is clear - Providing quality health care to the people at an affordable price.
Today, the name BDH has become synonymous with some of the best disease-eliminating healthcare products.
Recognition and Registration of Research & Development
(R & D) Centre by Department of Scientific and Industrial Research (DSIR),
Ministry of Science & Technology, Govt. of India.
R & D Centre team comprises of experienced members engaged in research towards developing
finished dosage formulations. We have good experience in formulation development for solid
orals, topical preparations& parenteral including pre-filled syringes. We have been designing
effective strategies for formulation development and providing affordable products. As per our
long term plan, now we are also focusing on New Drug Delivery systems (NDDS). We have a
track record of trouble-free technology transfer, scale-up, optimization, exhibit batch trials etc.
We ensure that our process development is encompassed with Quality by Design concepts,
Quality Risk Assessment and the cGMP requirements.
Formulation Development
Formulation Development has been gearing up for a state-of- the-art R & D facility. The current
R & D activities are also approved by the Ministry of Science and Technology, Government
of India. The centre is well equipped with various equipment and technologies required for
conducting high quality research activities and prototype equipment as that of manufacturing
facilities.
The key activities of R & D-Formulations are:
The key activities of R & D-Formulations are:
-
Novel Drug Delivery System (NDDS)
R & D in this area attempts to improve the efficiency with which the medicine is
absorbed in the body. Novel Drug Delivery Systems (NDDS) efforts are directed towards:
-
Controlled Release : Our Research concentrates on sustained and delayed release.
-
Novel Dosage Formulations : In the novel dosage form, the company concentrates on the following
therapeutic segments:
- Oncology -Anti Amoebic - Anthelmintic etc.
-
Manufacturing of new generic products
-
The Formulation R & D Capability includes
- Design and development of new dosage forms
- Pre formulation studies
- Lab / pilot scale studies
- Process optimization/validation studies
- Stability studies as per ICH guidance
- Technology Transfer of new products
- Technical supports and troubleshooting to manufacturing location
- Technology and latest development
Analytical Development
The Analytical R & D group is well supported by analytical development team which is
committed for development of analytical methodologies that provide precise, accurate and
reproducible data intime frame. Key activities include development, verification& validation of
various analytical test procedures to analyse Assay, Impurities/related substances, Content
Uniformity, Dissolution, Residual Solvents and other test procedures including in-house test
procedures for critical quality attribute parameters to establish and ensure quality of product and
finalization of Specifications as per ICH Guidelines with justification.